Central Venous Catheter Market Central Venous Catheter Market | Page 2

and peripherally-inserted central catheter (PICC). Non-tunneled catheters segment is expected to hold larger
share of the market due to its use in emergency cases for withdrawing blood.
Based on administration, market is bifurcated into subcutaneous and intravenous. Subcutaneous segment is
expected to lead the market owing to increasing preference by physicians. The complications reported by this
method are very less in comparison to others, small-gauge needle is required at a time, easy management
(especially for home treatment) and infusions can be stopped anytime.
In terms of property, market is split into antimicrobial and non-antimicrobial catheter. Antimicrobial segment is
anticipated to register significant growth owing to their increased use since they reduce the risk of microbial
infection. On the basis of end user, market is divided into clinics, hospitals, diagnostic centers, and ambulatory
surgery centers. Hospital segment leads the market growth owing to quality healthcare services offered by
hospitals.
Geographically, market is segmented as North America, Latin America, Europe, Asia Pacific and Middle East &
Africa. North America is expected to dominate the market owing to increasing healthcare facilities and
increasing rate of medical development. Other factors for the dominance are increasing investment and large
number of manufacturers in the region.
The key market players in central venous catheter market comprise Dickinson and Company, Citius
Pharmaceuticals, Edwards Lifesciences Corporation, B. Braun Melsungen AG, Cook Medical, AngioDynamics,
Vogt Medical, Becton, Guangdong Baihe Medical Technology Co. Ltd., TuoRen Medical, SCW Medicath Ltd., Intra
Special Catheters GmbH, Kimal, ZOLL Medical Corporation, Vygon Ltd., Lepu Medical Technology Co., Ltd.,
Smiths Medical, and Teleflex Incorporated.
Browse Related Category Market Reports @
https://www.millioninsights.com/industry/medical-devices